Quarterly ResultMay 7, 2026, 05:32 PM
Syra Health Q1 Net Income $240,979; Revenue +22.4% to $2.27M
AI Summary
Syra Health Corp. reported a significant turnaround in Q1 2026, achieving a net income of $240,979 compared to a net loss of $472,265 in Q1 2025. Net revenues increased by 22.4% to $2.27 million, driven by strong growth in Population Health services. The company also saw a substantial increase in cash from operating activities and deferred revenue, though it continues to acknowledge substantial doubt about its ability to continue as a going concern.
Key Highlights
- Net income was $240,979 in Q1 2026, a significant improvement from a net loss of $472,265 in Q1 2025.
- Net revenues increased by 22.4% to $2,273,520 in Q1 2026, up from $1,857,774 in Q1 2025.
- Gross profit surged by 64.8% to $971,255 in Q1 2026, compared to $589,156 in Q1 2025.
- Operating expenses decreased by 26.6% to $780,272 in Q1 2026 from $1,062,490 in Q1 2025.
- Cash and cash equivalents rose to $2,922,318 as of March 31, 2026, from $1,614,733 at December 31, 2025.
- Net cash provided by operating activities increased to $1,361,945 in Q1 2026 from $158,231 in Q1 2025.
- Deferred revenue significantly increased to $750,524 at March 31, 2026, from $16,611 at December 31, 2025.
- The company continues to acknowledge "substantial doubt" about its ability to continue as a going concern.
Price Impact
More from SYRA